Skip to main content

Santen Pharmaceutical

Santen Pharmaceutical Co Ltd is a Japanese pharmaceutical company specialized in ophthalmic research, development, and prescription eye care treatments. The company formulates, manufactures, and markets prescription pharmaceuticals, over-the-counter eye drops, and surgical devices for eye conditions including glaucoma, dry eye, and retinal disorders. Revenue is principally generated from the sale of branded ophthalmic medications through prescription channels, hospitals, and pharmacies. Core end markets encompass ophthalmology clinics, eye hospitals, and prescription consumers across Japan, Asia-Pacific, Europe, and the Americas. Santen Pharmaceutical holds the dominant market leadership position in the Japanese prescription ophthalmic market and a prominent international footprint. The company is headquartered in Osaka, Japan, and its shares trade on the Tokyo Stock Exchange.

9 of the funds FundTelligence covers report a position in Santen Pharmaceutical.

Legal name
Santen Pharmaceutical Co. Ltd.
Sector
Health Care
Country
Japan
Funds holding it
9
Exposure themes
Ageing & Longevity, Healthy Ageing & Function, Vision

Funds holding Santen Pharmaceutical

Showing the 8 largest of 9 funds holding it.

Loading...